Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2026-05-18 @ 8:59 AM
Study NCT ID:
NCT01362660
Status:
COMPLETED
Last Update Posted:
2013-02-06
First Post:
2011-05-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Infants With Potential Exposure to Tanezumab Before Birth
Sponsor:
Pfizer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A4091055
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None